Fresenius is a global healthcare company providing products and services for critically and chronically ill patients across (bio)pharma, clinical nutrition, MedTech, dialysis and hospital operations.
Fresenius is a global healthcare company focused on therapy, providing system-critical products and services for the care of critically and chronically ill patients. Headquartered in Bad Homburg vor der Höhe, Germany, the group operates across Europe, the Americas and other global markets, and traces a heritage of more than 100 years. Annual revenue reached €21.5 billion in fiscal year 2024, with around 176,000 employees excluding Fresenius Medical Care.
The group's activities span several heavily regulated fields: (bio)pharma, clinical nutrition, medical technology, dialysis products and services, and hospital operations. Fresenius Kabi supplies products for critically and chronically ill patients. Fresenius Helios is Europe's leading private hospital operator. Fresenius Medical Care, held as an investment, is the world's leading provider of dialysis products and services, serving approximately 4.5 million patients worldwide.
Under the #FutureFresenius programme, the company is concentrating on three therapy platforms: (Bio)Pharma including clinical nutrition, MedTech, and Care Provision. The stated priorities include affordable, accessible and innovative healthcare products, quality in clinical care, and continued growth in the evolving healthcare landscape.
